Measurements on a standard phantom and a clinical data set of patients with Duchenne muscular dystrophy (DMD) were used to validate a novel robust reference frequency method approach, which outperformed typical imaging strategies.

The new results make HERCULES the first and only study to demonstrate reduced CDP in nrSPMS. | Image credit: Juan Gärtner - stock-adobe.com

Tolebrutinib Delays Disability Progression in Nonrelapsing Secondary Progressive MS

By Rose McNulty

September 3rd 2024

The HERCULES study of tolebrutinib is the first and only to show reduced confirmed disability progression at 6 months in nonrelapsing secondary progressive multiple sclerosis (MS).

Multiple sclerosis diagnosis | Image credit: Vitalii Vodolazskyi - stock.adobe.com

Novel Risk Stratification Tool Shows Promise in MS

By Rose McNulty

August 16th 2024

A predictive tool considering disease duration, age at disease onset, age, and Expanded Disability Status Scale score estimated patients’ risk of transition to secondary progressive multiple sclerosis (MS).

The study suggests the codesigned EWWMS program filled a need for reliable and evidence-based nutrition information for patients with MS. | Image credit: Studio Romantic - stock.adobe.com

Online Interventions Can Improve Dietary Behaviors in People With MS

By Rose McNulty

August 16th 2024

A codesigned online nutrition program could potentially fill a need for reliable and evidence-based nutrition information for patients with multiple sclerosis (MS).

...

6 7 8 9 10

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

Do Not Sell My Information

Terms & Conditions